FLEX: A randomized, multicenter, phase III study of cetuximab in combination with cisplatin/vinorelbine (CV) versus CV alone in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC)

被引：92

作者：

Pirker, R.

Szczesna, A.

von Pawel, J.

Krzakowski, M.

Ramlau, R.

Park, K.

Gatzemeier, U.

Bajeta, E.

Emig, M.

Pereira, J. R.

机构：

[1] Med Univ Vienna, Vienna, Austria

[2] Mazowieckie Ctr Leczenia Chorob Pluc & Gruzl, Otwock, Poland

[3] Asklepios Fachkliniken Muenchen Gauting, Gauting, Germany

[4] Ctr Onkol, Inst Marii Sklodowskie, Warsaw, Poland

[5] Wielkopolskie Ctr Chorob Pluc & Gruzlicy, Poznan, Poland

[6] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea

[7] Hosp Grosshansdorf, Hamburg, Germany

[8] Fdn IRCCS, Ist Nazl Tumori, Milan, Italy

[9] Merck Serono, Darmstadt, Germany

[10] Inst Canc Arnaldo Vieira de Carvalho, Sao Paulo, Brazil

来源：

关键词：

D O I：

10.1200/jco.2008.26.15_suppl.3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：1